Inflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategies
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume 291, Issue 1, Pages 11-31
Publisher
Wiley
Online
2021-09-27
DOI
10.1111/joim.13380
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
- (2021) Geltrude Mingrone et al. LANCET
- Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model
- (2021) Yasmeen M Attia et al. BIOCHEMICAL PHARMACOLOGY
- G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment
- (2021) Ming Yang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity
- (2021) Vinod K. Rustgi et al. GASTROENTEROLOGY
- Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
- (2021) Michael Dudek et al. NATURE
- Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis
- (2021) Shubham A. Salunkhe et al. ADVANCED DRUG DELIVERY REVIEWS
- Metabolically Healthy Obesity
- (2020) Matthias Blüher ENDOCRINE REVIEWS
- TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice
- (2020) Mingming Zhao et al. GASTROENTEROLOGY
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
- (2020) Frank Jühling et al. GUT
- Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis
- (2020) Jason S. Seidman et al. IMMUNITY
- Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study
- (2020) Philip N. Newsome et al. JOURNAL OF HEPATOLOGY
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Selective targeting of BD1 and BD2 of the BET proteins in cancer and immuno-inflammation
- (2020) Omer Gilan et al. SCIENCE
- Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
- (2020) Elaine W. Yu et al. PLOS MEDICINE
- Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future
- (2020) Sonja Lang et al. Cell Host & Microbe
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD
- (2020) Mingjuan Deng et al. JOURNAL OF ENDOCRINOLOGY
- Senolytic CAR T cells reverse senescence-associated pathologies
- (2020) Corina Amor et al. NATURE
- Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease
- (2020) Mohammad Zarei et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes
- (2020) Mihoko Yoshino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
- (2020) David Fernández-Ramos et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming
- (2020) Soung Won Jeong Diabetes & Metabolism Journal
- Changes in Adult Alcohol Use and Consequences During the COVID-19 Pandemic in the US
- (2020) Michael S. Pollard et al. JAMA Network Open
- BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination
- (2020) Hyunkyung Jung et al. JCI Insight
- The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells
- (2020) Parth Trivedi et al. Cell Metabolism
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adipogenesis and metabolic health
- (2019) Alexandra L. Ghaben et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma
- (2019) S. Di Matteo et al. PLoS One
- Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells
- (2019) Hai-xia Yu et al. MOLECULAR IMMUNOLOGY
- NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
- (2019) Stephen A. Harrison et al. HEPATOLOGY
- BMP 9 is a paracrine factor controlling liver sinusoidal endothelial cell fenestration and protecting from hepatic fibrosis
- (2019) Agnès Desroches‐Castan et al. HEPATOLOGY
- Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblastsin Liver Fibrosis
- (2019) Oliver Krenkel et al. Cells
- Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients
- (2019) Jessica R. Allegretti et al. Clinical Gastroenterology and Hepatology
- An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis
- (2019) Yanping Li et al. JOURNAL OF CONTROLLED RELEASE
- A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
- (2019) R.K. Kelley et al. Clinical and Translational Gastroenterology
- Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation
- (2019) Peng Zhao et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Hepatocyte Stress Increases Expression of YAP and TAZ in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis
- (2019) Meghan Mooring et al. HEPATOLOGY
- Metabolically healthy obesity: facts and fantasies
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting cardiac fibrosis with engineered T cells
- (2019) Haig Aghajanian et al. NATURE
- Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae
- (2019) Jing Yuan et al. Cell Metabolism
- Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2019) Stephen A Harrison et al. LANCET
- Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis
- (2019) Ross Dobie et al. Cell Reports
- Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2019) Bishuang Cai et al. Cell Metabolism
- Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design
- (2019) Quentin M. Anstee et al. Contemporary Clinical Trials
- A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial
- (2019) Marcos Pedrosa et al. Contemporary Clinical Trials
- Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
- (2019) Naga Chalasani et al. GASTROENTEROLOGY
- Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
- (2019) Guadalupe Garcia-Tsao et al. JOURNAL OF HEPATOLOGY
- A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury
- (2018) Takanori Konishi et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming
- (2018) Anette Christ et al. CELL
- Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
- (2018) Xinshou Ouyang et al. Cell Metabolism
- Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- (2018) Zobair Younossi et al. Clinical Gastroenterology and Hepatology
- Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice
- (2018) Cynthia Lebeaupin et al. HEPATOLOGY
- HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers
- (2018) Bilon Khambu et al. JOURNAL OF CLINICAL INVESTIGATION
- JKB-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study
- (2018) A.M. Diehl et al. JOURNAL OF HEPATOLOGY
- Endoplasmic Reticulum stress signaling and the pathogenesis of Non-Alcoholic Fatty Liver Disease
- (2018) Cynthia Lebeaupin et al. JOURNAL OF HEPATOLOGY
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice
- (2018) Yadong Zhai et al. MOLECULES
- Cell type-specific pharmacological kinase inhibition for cancer chemoprevention
- (2018) Manjeet Deshmukh et al. Nanomedicine-Nanotechnology Biology and Medicine
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- The coming of age of chaperone-mediated autophagy
- (2018) Susmita Kaushik et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
- (2018) Agampodi Promoda Perera et al. Scientific Reports
- Butyrate: A Double-Edged Sword for Health?
- (2018) Hu Liu et al. Advances in Nutrition
- Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects
- (2018) KEC Bouter et al. Clinical and Translational Gastroenterology
- The role of the microbiome in NAFLD and NASH
- (2018) Aleksandra A Kolodziejczyk et al. EMBO Molecular Medicine
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Konstantin Kazankov et al. Nature Reviews Gastroenterology & Hepatology
- Indian Hedgehog links obesity to development of hepatocellular carcinoma
- (2018) Yong Chun Chong et al. ONCOGENE
- Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
- (2018) Changyu Zhu et al. Science Translational Medicine
- Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap
- (2018) Youngmin A. Lee et al. Nature Communications
- BET Inhibition Improves NASH and Liver Fibrosis
- (2018) Sarah A. Middleton et al. Scientific Reports
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A
- (2017) Müjdat Zeybel et al. MOLECULAR THERAPY
- Single-cell spatial reconstruction reveals global division of labour in the mammalian liver
- (2017) Keren Bahar Halpern et al. NATURE
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
- (2017) Mariana X. Byndloss et al. SCIENCE
- Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach
- (2017) Li Li et al. Scientific Reports
- Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
- (2017) Daniel F. Hicks et al. Scientific Reports
- The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway
- (2017) Yasmeen M. Attia et al. Scientific Reports
- Microbiome therapeutics — Advances and challenges
- (2016) Mark Mimee et al. ADVANCED DRUG DELIVERY REVIEWS
- Na + /H + antiporter (NHE1) and lactate/H + symporters (MCTs) in pH homeostasis and cancer metabolism
- (2016) Laurent Counillon et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
- (2016) Ana L. Gomes et al. CANCER CELL
- Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease
- (2016) Brian Finan et al. CELL
- Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
- (2016) Xiaobo Wang et al. Cell Metabolism
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
- (2016) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- Function of Autophagy in Nonalcoholic Fatty Liver Disease
- (2016) Mark J. Czaja DIGESTIVE DISEASES AND SCIENCES
- The role of ER stress in lipid metabolism and lipotoxicity
- (2016) Jaeseok Han et al. JOURNAL OF LIPID RESEARCH
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- ER stress: Autophagy induction, inhibition and selection
- (2015) Harun-Or Rashid et al. Autophagy
- Glucoregulatory Relevance of Small Intestinal Nutrient Sensing in Physiology, Bariatric Surgery, and Pharmacology
- (2015) Frank A. Duca et al. Cell Metabolism
- Computational and Experimental Advances in Drug Repositioning for Accelerated Therapeutic Stratification
- (2015) Khader Shameer et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
- (2015) Inge Mannaerts et al. JOURNAL OF HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- The Amelioration of Hepatic Steatosis by Thyroid Hormone Receptor Agonists Is Insufficient to Restore Insulin Sensitivity in Ob/Ob Mice
- (2015) Alexandro J. Martagón et al. PLoS One
- Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
- (2014) M. Zhou et al. CANCER RESEARCH
- Hippo Pathway Activity Influences Liver Cell Fate
- (2014) Dean Yimlamai et al. CELL
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
- (2014) Edward S Chambers et al. GUT
- Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
- (2014) Ning Liang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy
- (2014) Hong-Min Ni et al. JOURNAL OF HEPATOLOGY
- Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD
- (2014) Á González-Rodríguez et al. Cell Death & Disease
- Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
- (2013) Daniel F. Vatner et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
- (2013) Nicolas Ochs et al. ANNALS OF INTERNAL MEDICINE
- Peroxisome proliferator-activated receptor δ
- (2013) Lazar A. Bojic et al. CURRENT OPINION IN LIPIDOLOGY
- Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma
- (2013) Darjus Felix Tschaharganeh et al. GASTROENTEROLOGY
- IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice
- (2013) Isaac T.W. Harley et al. HEPATOLOGY
- Liver sinusoidal endothelial cells and liver regeneration
- (2013) Laurie D. DeLeve JOURNAL OF CLINICAL INVESTIGATION
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice
- (2013) Xuelian Xiong et al. JOURNAL OF HEPATOLOGY
- Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
- (2013) Yukihiro Furusawa et al. NATURE
- IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation
- (2013) K.-M. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43
- (2013) Ikuo Kimura et al. Nature Communications
- Vismodegib
- (2012) C. M. Rudin CLINICAL CANCER RESEARCH
- Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
- (2012) Valentina Volynets et al. DIGESTIVE DISEASES AND SCIENCES
- The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control
- (2012) Dimitri J. Pournaras et al. ENDOCRINOLOGY
- Sterile Inflammation in the Liver
- (2012) Paul Kubes et al. GASTROENTEROLOGY
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
- (2012) Anne Vrieze et al. GASTROENTEROLOGY
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats
- (2012) Lin Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Hepatocarcinogenesis in FXR−/−Mice Mimics Human HCC Progression That Operates through HNF1α Regulation of FXR Expression
- (2012) Nian Liu et al. MOLECULAR ENDOCRINOLOGY
- FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model
- (2012) Ulrich Deuschle et al. PLoS One
- Autophagy in nonalcoholic steatohepatitis
- (2011) Muhammad Amir et al. Expert Review of Gastroenterology & Hepatology
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- The metabolic actions of glucagon revisited
- (2010) Kirk M. Habegger et al. Nature Reviews Endocrinology
- Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia–reperfusion
- (2010) I Ben Mosbah et al. Cell Death & Disease
- Toll-like receptors as targets in chronic liver diseases
- (2009) A Mencin et al. GUT
- GRP78 expression inhibits insulin and ER stress–induced SREBP-1c activation and reduces hepatic steatosis in mice
- (2009) Hélène L. Kammoun et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
- (2009) Kendle M. Maslowski et al. NATURE
- Autophagy regulates lipid metabolism
- (2009) Rajat Singh et al. NATURE
- Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
- (2009) Mary-Elizabeth Patti et al. Obesity
- Therapeutic potential of dithiolethiones for hepatic diseases
- (2009) Samuel Carroll Brooks et al. PHARMACOLOGY & THERAPEUTICS
- Fatty acid metabolism: target for metabolic syndrome
- (2008) Salih J. Wakil et al. JOURNAL OF LIPID RESEARCH
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
- Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
- (2008) B. S. Samuel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More